Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality?

Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):1789. doi: 10.26355/eurrev_202203_28320.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arrhythmias, Cardiac
  • Heart Block / drug therapy
  • Hormone Replacement Therapy
  • Humans
  • Methylprednisolone / therapeutic use
  • Polychondritis, Relapsing* / diagnosis
  • Polychondritis, Relapsing* / drug therapy

Substances

  • Methylprednisolone